本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

7.56
+0.02000.27%
盘前:7.54-0.0200-0.26%07:30 EDT
成交量:367.04万
成交额:2,787.07万
市值:16.55亿
市盈率:-5.35
高:7.75
开:7.60
低:7.36
收:7.54
52周最高:16.44
52周最低:6.23
股本:2.19亿
流通股本:1.85亿
量比:1.03
换手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
净资产收益率:-72.99%
总资产收益率:-34.95%
市净率:3.18
市盈率(LYR):-5.32

数据加载中...

2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities